血管生成抑制因子抗癌研究进展

Progress on Using Angiogenesis Inhibitors to Resist Tumor

血管生成抑制因子是近年来迅速发展的一类具抑制血管新生和抗癌作用的蛋白质,它在人体内能安全使用,并且不产生抗药性,有着广阔的应用前景.笔者综述了血管生成抑制因子的抗癌作用及其机理等的研究进展.

Based on its function of blocking the new blood vessel forming of tumor, and with its safety, the use foreground of angiogenesis inhibitors as an anti-tumor drug was broad. In the paper, the anti-tumor function and mechanism of angiogenesis inhibitors were reviewed.